U.S. market Closed. Opens in 1 day 57 minutes

CYAD | Celyad Oncology SA Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue102.00KN/AN/A5.00K6.00K3.12M3.54M8.52M3.00K146.00KN/A54.00K26.93K
Cost of Revenue69.00K1.44M1.52MN/AN/AN/A515.00K53.00K6.38M115.00K2.42M6.68M5.80M
Gross Profit33.00K-1.44M-1.52M5.00K6.00K3.12M3.02M8.47M-6.38M31.00K-2.42M-6.63M-5.77M
Operating Expenses8.49M20.26M26.91M26.24M29.38M41.28M29.63M34.08M29.68M19.92M11.08M-5.19M3.31M
Selling, General & Admin6.25M10.34M9.66M8.99M8.72M10.39M9.31M9.74M7.23M5.02M2.99M3.71M2.84M
Research & Development4.67M18.93M20.77M21.59M25.23M23.58M22.91M27.68M5.90M15.87M2.16MN/AN/A
Other Operating Expenses-2.43M-9.00M-3.53M-4.34M-4.58M7.32M-23.79M-2.52M-222.00K-963.00K-1.02M-2.84K-270.00
Operating Income-8.46M-40.86M-26.39M-26.24M-29.37M-38.17M-52.88M-25.61M-29.67M-16.44M-11.97M-1.44M-9.08M
Other Expenses / Income-54.00K-13.00K-111.00K-217.00K239.00K433.00K-3.52M2.00M558.00K-16.00K-1.53M-622.51K-51.81K
Before Tax Income-8.51M-40.87M-26.50M-17.20M-28.64M-37.43M-56.40M-23.61M-29.11M-16.45M-12.35M-2.15M-9.13M
Income Tax Expenses-191.00K65.00K10.00K297.00K-8.00K-1.11M-1.00K-6.00K-55.00K-2.48M-360.001.70M51.81K
Net Income-8.45M-40.94M-26.51M-17.50M-28.63M-36.31M-56.40M-23.61M-29.11M-16.45M-12.35M-2.15M-9.13M
Interest Expenses84.00K197.00K255.00K297.00K343.00K62.00K4.45M207.00K236.00K22.00K425.42K627.45K33.30K
Basic Shares Outstanding25.72M22.59M15.60M13.94M12.52M11.14M9.62M9.31M8.48M6.75M4.10M4.10M6.33M
Diluted Shares Outstanding25.72M22.59M15.60M13.94M12.52M11.14M9.62M9.33M8.49M6.75M4.10M4.10M6.33M
EBITDA-7.76M-39.70M-25.41M-15.73M-27.45M-36.56M-55.70M-21.99M-28.07M-15.31M-12.07M-12.00M-6.36M
EBITDA Margin-7,610.78%0.00%0.00%-314,640.00%-457,500.00%-1,173.74%-1,573.42%-257.97%-935,700.00%-10,489.73%0.00%-22,227.76%-23,621.68%
EBIT-8.55M-40.67M-26.25M-16.91M-28.30M-37.37M-51.94M-23.41M-28.93M-18.91M-11.92M173.72K-9.05M
EBIT Margin-8,387.25%0.00%0.00%-338,140.00%-471,616.67%-1,199.52%-1,467.29%-274.61%-964,433.33%-12,954.79%0.00%321.70%-33,600.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙